SPONSOR
Tel-Aviv Sourasky Medical Center
Total Trials
7
Recruiting
7
Phases
Phase 2
Conditions studied: Heart FailureHormone Receptor Positive Breast CancerRefractory AnginaCreutzfeldt-Jakob Disease (CJD)TNBC, Triple Negative Breast CancerEarly Breast CancerAdvanced Heart Failure
Tel-Aviv Sourasky Medical Center is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Heart Failure, Hormone Receptor Positive Breast Cancer, Refractory Angina, Creutzfeldt-Jakob Disease (CJD).
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Tel-Aviv Sourasky Medical Center
How many clinical trials has Tel-Aviv Sourasky Medical Center sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Tel-Aviv Sourasky Medical Center, of which 7 are actively recruiting participants. These trials cover conditions including Heart Failure, Hormone Receptor Positive Breast Cancer, Refractory Angina. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tel-Aviv Sourasky Medical Center research focus on?
Tel-Aviv Sourasky Medical Center clinical trials span Heart Failure, Hormone Receptor Positive Breast Cancer, Refractory Angina, Creutzfeldt-Jakob Disease (CJD), TNBC, Triple Negative Breast Cancer, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Tel-Aviv Sourasky Medical Center clinical trial?
To participate in a Tel-Aviv Sourasky Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tel-Aviv Sourasky Medical Center trials with current recruitment status updated daily.
Clinical Trials by Tel-Aviv Sourasky Medical Center
NCT03142659
Recruiting
Evaluation and Management of Heart Failure Patients
Heart Failure
NCT07646171
Recruiting
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)
Hormone Receptor Positive Breast Cancer
NCT01566175
Recruiting
Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization
Refractory Angina
NCT02818517
Recruiting
Evaluation and Management of Cardio Toxicity in Oncologic Patients
Heart Failure
NCT05746715
Recruiting
A Natural History Study of Preclinical Genetic Creutzfeldt-Jakob Disease (CJD)
Creutzfeldt-Jakob Disease (CJD)
NCT07327021 Phase 2
Recruiting
MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC
TNBC, Triple Negative Breast Cancer
NCT05271214
Recruiting
Conservative Management of Left Ventricular Assist Device Candidates
Advanced Heart Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology